We are live on ! Find out more
CC

Chicago Capital Portfolio holdings

AUM $4.15B
1-Year Est. Return 31.09%
This Fund
S&P 500
This Quarter Est. Return
+12.73%
1 Year Est. Return
+31.09%
3 Year Est. Return
+117.08%
5 Year Est. Return
+137.61%
10 Year Est. Return
–
AUM
$2.01B
AUM Growth
+$202M
Cap. Flow
+$14.9M
Cap. Flow %
0.74%
Top 10 Hldgs %
34.18%
Holding
238
New
11
Increased
56
Reduced
56
Closed
10

Top Buys

Rank Stock Value
1
TDC icon
Teradata
TDC
+$19M
2
UNH icon
UnitedHealth
UNH
+$15.2M
3
INTU icon
Intuit
INTU
+$11M
4
TSM icon
TSMC
TSM
+$9.83M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$9.27M

Top Sells

Rank Stock Value
1
ALBO
Albireo Pharma Inc
ALBO
+$29.4M
2
SIVB
SVB Financial Group
SIVB
+$23.7M
3
EW icon
Edwards Lifesciences
EW
+$20.7M
4
CCSI icon
Consensus Cloud Solutions
CCSI
+$13.6M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 27.58%
2 Healthcare 21.34%
3 Financials 14.12%
4 Communication Services 11.1%
5 Consumer Discretionary 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTVA icon
201
Corteva
CTVA
$52.6B
$255K 0.01%
4,221
– –
BAX icon
202
Baxter International
BAX
$13.5B
$253K 0.01%
6,237
– –
GSK icon
203
GSK
GSK
$104B
$253K 0.01%
7,100
– –
NUE icon
204
Nucor
NUE
$58.6B
$245K 0.01%
1,584
– –
NVS icon
205
Novartis
NVS
$297B
$243K 0.01%
2,640
– –
PRAA icon
206
PRA Group
PRAA
$663M
$242K 0.01%
6,220
– –
SONY icon
207
Sony
SONY
$137B
$231K 0.01%
+12,745
New +$221K
D icon
208
Dominion Energy
D
$60.8B
$231K 0.01%
4,129
-40
-1% -$2.34K
MTB icon
209
M&T Bank
MTB
$35.7B
$230K 0.01%
1,923
– –
PXD
210
DELISTED
Pioneer Natural Resource Co.
PXD
$224K 0.01%
1,096
– –
K
211
DELISTED
Kellanova
K
$223K 0.01%
3,546
– –
CME icon
212
CME Group
CME
$96.3B
$217K 0.01%
+1,131
New +$205K
EQIX icon
213
Equinix
EQIX
$101B
$216K 0.01%
+300
New +$211K
DD icon
214
DuPont de Nemours
DD
$18.5B
$216K 0.01%
2,395
– –
BEN icon
215
Franklin Resources
BEN
$17.6B
$216K 0.01%
8,004
– –
MNDY icon
216
monday.com
MNDY
$3.68B
$216K 0.01%
+1,510
New +$204K
PLTR icon
217
Palantir
PLTR
$295B
$207K 0.01%
24,525
– –
HAL icon
218
Halliburton
HAL
$26.9B
$205K 0.01%
6,490
– –
CHRW icon
219
C.H. Robinson
CHRW
$17.4B
$204K 0.01%
+2,055
New +$202K
MNTS icon
220
Momentus
MNTS
$76.3M
$139K 0.01%
19
– –
PSLV icon
221
Sprott Physical Silver Trust
PSLV
$12B
$133K 0.01%
16,000
– –
F icon
222
Ford
F
$58.5B
$128K 0.01%
+10,174
New +$127K
CIM
223
Chimera Investment
CIM
$1.04B
$121K 0.01%
7,167
– –
HWELU
224
DELISTED
Healthwell Acquisition Corp. I Unit
HWELU
$102K 0.01%
10,000
– –
LYG icon
225
Lloyds Banking Group
LYG
$89.5B
$69.6K ﹤0.01%
30,000
– –
6 7 8
9
10

Similar funds

SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Chicago Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Chicago Capital held 238 positions worth $2.01B, up 11% from $1.81B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Chicago Capital's Q1 2023 filing shows 11 new, 56 increased, 56 reduced and 10 closed positions. Its largest new stake was Factset: 1,141 shares worth $474K. The largest sale was Albireo Pharma Inc, an estimated $29.4M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Chicago Capital's largest Q1 2023 buy was Factset: 1,141 shares worth $474K.
  • Chicago Capital added most to Teradata in Q1 2023, an estimated $19M increase.
  • Chicago Capital's biggest Q1 2023 reduction was Edwards Lifesciences, cutting an estimated $20.7M.
  • Chicago Capital fully exited Albireo Pharma Inc in Q1 2023, selling an estimated $29.4M.
  • Chicago Capital's ten largest holdings make up 34% of its $2.01B portfolio in Q1 2023.
  • Chicago Capital opened 11 new positions and closed 10 in Q1 2023.
  • Chicago Capital's portfolio value rose 11% quarter-over-quarter to $2.01B.

Based on Chicago Capital's 13F filing for Q1 2023, filed 18 Apr 2023.